Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03523351 · ClinicalTrials.gov registry record · Phase 1
Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain
A Phase 1 study of Metastatic Solid Tumors of Metastatic Disease, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 78
- Enrollment target
- 9
- Study locations
NCT03523351 is a Phase 1 study of Metastatic Solid Tumors of Metastatic Disease that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 78 participants. The trial reports 9 study locations across 4 states.
The verdict
NCT03523351, a Phase 1 study of Metastatic Solid Tumors of Metastatic Disease, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 78 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of the study is to compare the outcome of patients who receive standard treatment versus those who receive preventative radiation and then standard treatment.
Conditions Studied
Interventions
- RADIATION Radiation Therapy
- DRUG Systemic Therapy
Study Locations (9)
New York
- Memorial Sloan Kettering Commack - Commack
- Memorial Sloan Kettering Westchester - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge - Basking Ridge
- Memorial Sloan Kettering Monmouth - Middletown
- Memorial Sloan Kettering Bergen - Montvale
Florida
- Baptist Alliance Miami Cancer Institute - Miami
Pennsylvania
- Lehigh Valley Health Network - Allentown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2024-04-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03523351
The ClinicalTrials.gov registry entry for NCT03523351 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Metastatic Solid Tumors of Metastatic Disease appearing as the primary indexed condition, and to 2 interventions - of which Radiation Therapy is the first listed.
NCT03523351 reports 9 study locations spanning 4 distinct geographic areas - top geographies include New York, New Jersey, Florida.
Frequently Asked Questions
What is clinical trial NCT03523351 about?
NCT03523351 is a clinical study titled "Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain". The purpose of the study is to compare the outcome of patients who receive standard treatment versus those who receive preventative radiation and then standard treatment.
What is the current status of trial NCT03523351?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 78 participants. The study started on 2018-05-01. Estimated completion is 2024-04-18.
What conditions does trial NCT03523351 study?
This clinical trial studies the following conditions: Metastatic Solid Tumors of Metastatic Disease.
What interventions are being tested in trial NCT03523351?
The interventions under investigation include: Radiation Therapy (RADIATION), Systemic Therapy (DRUG).
Who is sponsoring clinical trial NCT03523351?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03523351 being conducted?
This trial has 9 study locations across Florida, New Jersey, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.